This story was first published on RealAgriculture.com on Jan 5, 2026.
A quiet pharmaceutical revolution is reshaping the grocery aisle — and with it, demand signals across the agri-food supply chain.
GLP-1 drugs, originally developed for treating Type 2 diabetes, are now increasingly being used for weight loss, with about 12 per cent of adults in North America currently using them.
Read more:
- ‘Excellent first step’: Sask. farmer welcomes progress on trade deal with China
- Sask. Premier Scott Moe calls tariff deal with China a ‘tremendous, landmark agreement’
- Short-term canola questions answered, long-term outlook still uncertain: business expert
That number is expected to grow quickly, with implications for what people eat, how much they consume, and where they shop.
JP Frossard, consumer goods analyst at Rabobank, joined RealAgriculture to explain why GLP-1s are no longer just a pharmaceutical story.
“The first impact is people on those drugs, they eat less,” he says. “Once you eat less, you become more careful — what are you actually going to eat?”
That shift in food choices is already playing out in noticeable ways. Consumers are moving away from empty-calorie items such as sugary snacks, fried foods, and alcohol, and turning instead to higher-protein, higher-fibre options.
This trend overlaps with broader movements toward gut health, lower ultra-processed food consumption, and “natural” eating patterns, reinforcing demand for animal protein, dairy, and minimally-processed staples.
Frossard says we should expect to see more product innovation focused on fibre and protein content, smaller portion sizes, and reformulated flavour profiles to match altered taste perceptions among GLP-1 users.
“There’s a lot of challenge in rethinking formulations. Maybe we don’t need cookies as sweet as before. Maybe saltiness perception is different.”
The changes also carry upstream implications for agricultural production.
If calorie consumption drops and quality trumps quantity, sectors such as sugar, snack ingredients, and soft drinks may face headwinds, while animal protein and fibre-rich commodities could see growth opportunities.
Read the Rabobank report on the topic here.
Listen to RealAg on the Weekend, Saturdays at 4 p.m. and Sundays at 1 p.m. on 650 CKOM and 980 CJME.
Read more:









